-
公开(公告)号:EP3063143B1
公开(公告)日:2018-05-16
申请号:EP14800191.0
申请日:2014-10-29
申请人: Novartis AG
发明人: BAGDANOFF, Jeffrey T. , DING, Yu , HAN, Wooseok , HUANG, Zilin , JIANG, Qun , JIN, Jeff Xianming , KOU, Xiang , LEE, Patrick , LINDVALL, Mika , MIN, Zhongcheng , PAN, Yue , PECCHI, Sabina , PFISTER, Keith Bruce , POON, Daniel , RAUNIYAR, Vivek , WANG, Xiaojing Michael , ZHANG, Qiong , ZHOU, Jianguang , ZHU, Shejin
IPC分类号: C07D405/14 , C07D413/14 , C07D213/73 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/06 , C07D405/04 , C07D409/04 , C07D241/20 , A61K31/4418 , A61P35/00
CPC分类号: A61K31/497 , A61K31/44 , A61K31/4433 , A61K31/4436 , A61K31/4439 , A61K31/4545 , A61K31/4965 , A61K31/506 , A61K31/5355 , A61K31/5377 , A61K31/5383 , A61K31/553 , A61K45/06 , A61K2121/00 , C07D213/73 , C07D241/20 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/06 , C07D405/04 , C07D405/14 , C07D409/04 , C07D413/14 , C07D498/04
摘要: The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.
-
公开(公告)号:EP3177593A1
公开(公告)日:2017-06-14
申请号:EP15750132.1
申请日:2015-08-03
申请人: Novartis AG , He, Haiying , Jiang, Zhigan , Xia, Jianhua
发明人: FIDALGO, Javier De Vicente , HU, Cheng , LI, Xiaolin , LU, Peichao , MERGO, Wosenu , MUTNICK, Daniel , RECK, Folkert , RIVKIN, Alexey , SKEPPER, Colin Keith , WANG, Xiaojing Michael , XU, Yongjin , JIANG, Zhigan , HE, Haiying , XIA, Jianhua
IPC分类号: C07D215/22 , C07D215/38 , A61K31/4704 , A61P31/04
CPC分类号: C07D215/38 , A61K31/4709 , A61K31/496 , A61K31/5377 , A61K31/5386 , A61K45/06 , C07D215/22 , C07D401/04 , C07D401/14 , C07D405/14 , C07D413/14 , C07D419/14 , C07D471/04 , C07D471/10 , C07D487/10 , C07D498/10
摘要: as further described herein. The invention further provides pharmaceutical compositions comprising a compound of Formula (I) and methods of using the compounds and compositions to treat bacterial infections.
摘要翻译: 本发明属于医药化学领域,涉及抑制细菌促旋酶的化合物及其药物组合物。 该化合物可用作细菌促旋酶活性和细菌感染的抑制剂,并具有本文进一步描述的式(I)的结构。 本发明进一步提供了包含式(I)化合物的药物组合物以及使用该化合物和组合物治疗细菌感染的方法。
-
3.2 -ARYLAMINOQUINAZOLINES FOR TREATING PROLIFERATIVE DISEASES 审中-公开
标题翻译: 2- ARYLAMINOCHINAZOLINE用于治疗增殖性疾病公开(公告)号:EP2307385A1
公开(公告)日:2011-04-13
申请号:EP09765892.6
申请日:2009-06-18
申请人: Novartis AG
发明人: JAIN, Rama , LIN, Xiaodong , NG, Simon C. , PFISTER, Keith B. , RAMURTHY, Savithri , RICO, Alice , SUBRAMANIAN, Sharadha , WANG, Xiaojing Michael
IPC分类号: C07D239/84 , A61K31/517 , A61P35/00 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/10 , C07D403/14 , C07D405/14 , C07D413/10 , C07D413/14 , C07D417/04 , C07D417/14
CPC分类号: C07D417/04 , C07D239/84 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/10 , C07D403/14 , C07D405/14 , C07D413/10 , C07D413/14 , C07D417/14
摘要: The invention provides novel compounds that are inhibitors of PDKI. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or composition.
-
公开(公告)号:EP3759113A1
公开(公告)日:2021-01-06
申请号:EP19713572.6
申请日:2019-02-26
申请人: Novartis AG
发明人: DAUPHINAIS, Maxime , JAIN, Rama , KOESTER, Dennis Christofer , MANNING, James R. , MARX, Vanessa , POON, Daniel , WAN, Lifeng , WANG, Xiaojing Michael , YIFRU, Aregahegn , ZHAO, Qian
IPC分类号: C07D487/14 , C07D498/14 , A61K31/4985 , A61K31/5025 , A61P31/16
-
5.AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS 有权
标题翻译: AMINOHETEROARYLBENZAMIDE ALS KINASEINHIBITOREN公开(公告)号:EP3063143A1
公开(公告)日:2016-09-07
申请号:EP14800191.0
申请日:2014-10-29
申请人: Novartis AG
发明人: BAGDANOFF, Jeffrey T. , DING, Yu , HAN, Wooseok , HUANG, Zilin , JIANG, Qun , JIN, Jeff Xianming , KOU, Xiang , LEE, Patrick , LINDVALL, Mika , MIN, Zhongcheng , PAN, Yue , PECCHI, Sabina , PFISTER, Keith Bruce , POON, Daniel , RAUNIYAR, Vivek , WANG, Xiaojing Michael , ZHANG, Qiong , ZHOU, Jianguang , ZHU, Shejin
IPC分类号: C07D405/14 , C07D413/14 , C07D213/73 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/06 , C07D405/04 , C07D409/04 , C07D241/20 , A61K31/4418 , A61P35/00
CPC分类号: A61K31/497 , A61K31/44 , A61K31/4433 , A61K31/4436 , A61K31/4439 , A61K31/4545 , A61K31/4965 , A61K31/506 , A61K31/5355 , A61K31/5377 , A61K31/5383 , A61K31/553 , A61K45/06 , A61K2121/00 , C07D213/73 , C07D241/20 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/06 , C07D405/04 , C07D405/14 , C07D409/04 , C07D413/14 , C07D498/04
摘要: The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.
摘要翻译: 本发明提供式(I)的化合物或其盐; 和这些化合物的治疗用途。 本发明还提供包含这些化合物的药物组合物,以及包含这些化合物与治疗性助剂的组合物。
-
-
-
-